States struggle with contact tracing, Pence isn't taking hydroxychloroquine

Here are the latest coronavirus updates from around the world.
COVID-19 Testing Begins in Historic Black Neighborhoods in Altamonte Springs, US
Health workers test people in cars for COVID-19 at a mobile testing site at the Apostolic Church of Christ in Altamonte Springs, Fla. on April 21, 2020.Paul Hennessy / Barcroft Media via Getty Images file

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
SUBSCRIBE

States across the country are reopening their economies, but they’re struggling with what public health officials have called a key component aimed at preventing the spread of coronavirus — contact tracing.

President Donald Trump might be taking hydroxychloroquine as a prophylactic against COVID-19, but that doesn’t mean his vice president is.

"My physician hasn’t recommended that, but I wouldn’t hesitate to take the counsel of my doctor," Mike Pence told Fox News on Tuesday.

Walter Barton, 64, was put to death in Missouri on Tuesday. His was the first execution in the United States since the World Health Organization declared the coronavirus outbreak a global pandemic.

Here's what to know about the coronavirus, plus a timeline of the most critical moments:

Download the NBC News app for latest updates on the coronavirus outbreak.

This live coverage has now ended. Continue to May 20 coronavirus news.

Trump admin taps startup to build first stockpile of key drug ingredients

Seeking to secure the nation's supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation's first strategic stockpile of key ingredients needed to make medicines.

The agreement was signed Monday with Phlow Corp., a generic drug maker based in Virginia. According to a news release to be made public Tuesday, the project will use federal funds from the Biomedical Advanced Research and Development Authority under the Department of Health and Human Services.

The goal is twofold: to enable the U.S. to manufacture essential drugs at risk of shortage and to create a reserve of active pharmaceutical ingredients to reduce the dependence on foreign suppliers.

Read the full story here

Essential workers balance low pay, COVID-19 worries while staying open for America